Related Experiment Videos
Population pharmacokinetics of vancomycin in Japanese pediatric patients
1Department of Pharmacy, Tokyo Medical and Dental University Hospital, Japan.
Insights
This study analyzed vancomycin pharmacokinetics in Japanese pediatric patients with MRSA infections. Vancomycin clearance is age-dependent in children, informing optimized dosing strategies.
Area of Science:
- Pharmacology
- Pediatric Infectious Diseases
- Pharmacokinetics
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) infections pose a significant threat in pediatric populations.
- Vancomycin (VCM) is a critical antibiotic for treating MRSA infections, but its efficacy depends on achieving therapeutic serum concentrations.
- Understanding the population pharmacokinetic (PPK) profile of vancomycin in pediatric patients is essential for optimizing treatment outcomes.
Framework:
- A one-compartment linear pharmacokinetic model was employed.
- Population pharmacokinetic analysis was performed using the NONMEM program with the first-order conditional estimation method.
- Key pharmacokinetic parameters, vancomycin clearance (CL) and volume of distribution (Vd), were evaluated.
Implementation:
- Serum vancomycin concentration data from 181 samples across 49 Japanese pediatric patients were analyzed.
- Covariates including postnatal age (AGE) and body weight (BWT) were assessed for their influence on pharmacokinetic parameters.
- The analysis revealed age-dependent changes in vancomycin clearance normalized by body weight.
Implications:
- Vancomycin clearance normalized by body weight increases with age up to one year and decreases thereafter.
- The volume of distribution normalized by body weight remained independent of age.
- These findings support the development of age-specific dosing guidelines for vancomycin therapy in pediatric MRSA infections to improve treatment efficacy and minimize toxicity.
Abstract:
The population pharmacokinetic profile of vancomycin (VCM) in Japanese pediatric patients infected with methicillin-resistant Staphylococcus aureus was analyzed using 181 samples of serum concentration data from 49 patients obtained in routine drug monitoring. The one-compartment linear model was adopted, where the VCM clearance (CL) and the distribution volume (Vd) were correlated with covariates such as postnatal age (AGE) and body weight (BWT). The population pharmacokinetic analysis program NONMEM with the first-order conditional estimation method was used. The results showed that the population mean clearance normalized by BWT increases with AGE up to 1 year of age [CL(L/hour per kg) = 0.1 19 + 0.0619 x (AGE - 1)] and decreases with age over 1 year old [CL(L/hour per kg) = 0.119 + 0.00508 x (1 - AGE)]. The population mean of the distribution volume normalized by BWT was independent of AGE (Vd (L/kg) = 0.522). The interindividual variability of CL was 39.6%, and that of Vd was 18.8%. The intraindividual, residual variability was 34.6%. These results were compared with those in other articles, and a guideline for dosage adjustment in VCM therapy is discussed.